Editas Medicine (EDIT) Receivables - Net: 2015-2025
Historic Receivables - Net for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to $8.1 million.
- Editas Medicine's Receivables - Net rose 6352.38% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 6352.38%. This contributed to the annual value of $16.3 million for FY2024, which is 59.67% up from last year.
- Editas Medicine's Receivables - Net amounted to $8.1 million in Q3 2025, which was up 1,282.65% from $588,000 recorded in Q2 2025.
- In the past 5 years, Editas Medicine's Receivables - Net registered a high of $16.3 million during Q4 2024, and its lowest value of $120,000 during Q3 2022.
- For the 3-year period, Editas Medicine's Receivables - Net averaged around $3.7 million, with its median value being $588,000 (2025).
- Its Receivables - Net has fluctuated over the past 5 years, first plummeted by 95.59% in 2021, then surged by 6,352.38% in 2025.
- Over the past 5 years, Editas Medicine's Receivables - Net (Quarterly) stood at $267,000 in 2021, then soared by 1,826.97% to $5.1 million in 2022, then soared by 98.00% to $10.2 million in 2023, then surged by 59.67% to $16.3 million in 2024, then spiked by 6,352.38% to $8.1 million in 2025.
- Its last three reported values are $8.1 million in Q3 2025, $588,000 for Q2 2025, and $510,000 during Q1 2025.